Gunderson Capital Management Inc. Dexcom Inc Transaction History

Gunderson Capital Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $53,586 - $71,791	-687 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $124,927 - $147,738	-1,308 Reduced 65.56%	687 $281,000
Q2 2020 Aug 10, 2020	SELL	$62.68 - $105.34 $116,020 - $194,984	-1,851 Reduced 48.13%	1,995 $809,000
Q1 2020 May 12, 2020	BUY	$47.79 - $75.63 $29,629 - $46,890	620 Added 19.22%	3,846 $1.04 Million
Q4 2019 Jan 31, 2020	BUY	$36.62 - $57.29 $8,935 - $13,978	244 Added 8.18%	3,226 $706,000
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $105,950 - $130,611	2,982 New	2,982 $445,000

1,021

352M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Gunderson Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Gunderson Capital Management Inc. with notifications on news.